FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
FDA approves brain cancer drug, targeting the IDH mutation discovered at the Johns Hopkins Kimmel Cancer Center. Credit: Elizabeth Cook Location: Baltimore…
FDA approves brain cancer drug, targeting the IDH mutation discovered at the Johns Hopkins Kimmel Cancer Center. Credit: Elizabeth Cook Location: Baltimore…
Read More
About Author
